Trovagene Inc (NASDAQ:TROV)

4.06
Data as of Aug 21
 -0.31 / -7.09%
Today’s Change
2.97
Today|||52-Week Range
9.14
-29.27%
Year-to-Date

Today’s Trading

Previous close4.37
Today’s open4.54
Day’s range-- - --
Volume188,316
Average volume (3 months)87,254
Market cap$82.6M
Dividend yield--
Data as of 08/21/2014

Growth & Valuation

Earnings growth (last year)+21.35%
Earnings growth (this year)-5.00%
Earnings growth (next 5 years)--
Revenue growth (last year)-42.44%
P/E ratioNM
Price/Sales375.92
Price/Book4.05

Competitors

 Today’s
change
Today’s
% change
CGIXCancer Genetics Inc-0.05-0.56%
APPYVenaxis Inc-0.01-0.57%
GBIMGlobeImmune Inc-0.02-0.21%
GALTGalectin Therapeutic...-0.22-4.33%
Data as of 08/21/2014

Financials

Next reporting dateNovember 13, 2014
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$259.2K
Annual profit (last year)-$11.8M
Net profit margin-4,555.88%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Antonius P. Schuh
Chief Financial Officer
Stephen L. Zaniboni
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.